ebselen has been researched along with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alonso, C; Barrado-Gil, L; Campillo, NE; Cuesta-Geijo, MÁ; Gil, C; Ginex, T; Maestro, I; Martinez, A; Nozal, V; Ramírez, D; Urquiza, J | 1 |
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
Cao, H; Chen, H; Han, X; Huang, Y; Liu, J; Peng, C; Rao, L; Ren, Y; Sheng, C; Su, C; Tu, J; Wan, C; Wan, J; Wen, W | 1 |
1 review(s) available for ebselen and 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
Article | Year |
---|---|
COVID-19: Drug Targets and Potential Treatments.
Topics: Amino Acid Sequence; Animals; Antiviral Agents; COVID-19 Drug Treatment; Drug Repositioning; Enzyme Inhibitors; Humans; Immunity, Innate; SARS-CoV-2 | 2020 |
2 other study(ies) available for ebselen and 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
Article | Year |
---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of
Topics: Allosteric Site; Antifungal Agents; Azoles; Biofilms; Candida albicans; Candida parapsilosis; Drug Resistance, Fungal; Enzyme Inhibitors; Fructose-Bisphosphate Aldolase; Fungal Proteins; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Structure-Activity Relationship | 2022 |